Literature DB >> 10063657

Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic.

D Wilkinson1, S S Abdool Karim, A Harrison, M Lurie, M Colvin, C Connolly, A W Sturm.   

Abstract

Sexually transmitted infections (STIs) are of major public health concern in developing countries, not least because they facilitate transmission of human immunodeficiency virus (HIV). The present article presents estimates of the prevalence, on any given day, of STIs among women in rural South Africa and the proportion who are asymptomatic, symptomatic but not seeking care, and symptomatic and seeking care. The following data sources from Hlabisa district were used: clinical surveillance for STI syndromes treated in health facilities, microbiological studies among women attending antenatal and family planning clinics, and a community survey. Population census provided denominator data. Adequacy of drug treatment was determined through quality of care surveys. Of 55,974 women aged 15-49 years, a total of 13,943 (24.9%) were infected on any given day with at least one of Trichomonas vaginalis, Neisseria gonorrhoeae, Chlamydia trachomatis, or Treponema pallidum. Of the women investigated, 6697 (48%) were asymptomatic, 6994 (50%) were symptomatic but not seeking care, 238 (1.7%) were symptomatic and would seek care, and 14 (0.3%) were seeking care on that day. Only 9 of the 14 women (65%) were adequately treated. STIs remained untreated because either women were asymptomatic or the symptoms were not recognized and acted upon. Improved case management alone is therefore unlikely to have a major public health impact. Improving partner treatment and women's awareness of symptoms is essential, while the potential of mass STI treatment needs to be explored.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; English Speaking Africa; Estimation Technics; Health; Health Services; Infections; Measurement; Population; Population Characteristics; Prevalence; Reproductive Health--women; Reproductive Tract Infections; Research Methodology; Research Report; Rural Population--women; Sexually Transmitted Diseases--prevention and control; Sexually Transmitted Diseases--women; Signs And Symptoms--women; South Africa; Southern Africa; Treatment--women; Utilization Of Health Care--women; Women

Mesh:

Year:  1999        PMID: 10063657      PMCID: PMC2557569     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  37 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Effectiveness and cost effectiveness of syndromic sexually transmitted infection packages in South African primary care: cluster randomised trial.

Authors:  M Colvin; M O Bachmann; R K Homan; D Nsibande; N M Nkwanyana; C Connolly; E B Reuben
Journal:  Sex Transm Infect       Date:  2006-05-24       Impact factor: 3.519

3.  An anthropologically based model of the impact of asymptomatic cases on the spread of Neisseria gonorrhoeae.

Authors:  Ashley Hazel; Simeone Marino; Carl Simon
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

4.  Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Authors:  Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Sex Transm Infect       Date:  2015-10-28       Impact factor: 3.519

5.  Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women.

Authors:  Collin M Price; Remco P H Peters; Janré Steyn; Maanda Mudau; Dawie Olivier; Lindsey De Vos; Erika Morikawa; Marleen M Kock; Andrew Medina-Marino; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2018-05       Impact factor: 2.830

Review 6.  Genital inflammation, immune activation and risk of sexual HIV acquisition.

Authors:  Jo-Ann S Passmore; Heather B Jaspan; Lindi Masson
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

7.  Correlates of prevalent sexually transmitted infections among participants screened for an HIV incidence cohort study in Kisumu, Kenya.

Authors:  Fredrick Odhiambo Otieno; Richard Ndivo; Simon Oswago; Sherri Pals; Robert Chen; Timothy Thomas; Ernesta Kunneke; Lisa A Mills; Eleanor McLellan-Lemal
Journal:  Int J STD AIDS       Date:  2014-05-08       Impact factor: 1.359

Review 8.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Syndromic management and STI control in urban Peru.

Authors:  Jesse L Clark; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Jeffrey D Klausner; Thomas J Coates; Carlos F Caceres
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

Review 10.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.